See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356857_2012_Trius_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001356857, Trius Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 66,687,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,037,000 |
| 3 | remainder_Assets | 401,000 |
| 4 | LiabilitiesCurrent | 18,234,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,339,000 |
| 9 | ResearchAndDevelopmentExpense | 49,503,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 41,011,000 |
| 12 | remainder_NetIncome | 1,581,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 68,125,000 |
| 1 | Liabilities | 18,234,000 |
| 2 | Expenses | 60,842,000 |
| 3 | Revenues | 41,011,000 |
| 4 | StockholdersEquity | 49,891,000 |
| 5 | NetIncome | -18,250,000 |
| 6 | ComprehensiveNetIncome | -18,250,000 |
| 7 | BaseVar | 94,896,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.10 |
| 9 | EconomicCapitalRatio | 3.09 |
Edgar->Model Mapping
Feature Distribution
